04:34 PM EDT, 10/30/2024 (MT Newswires) -- Bausch Health Companies ( BHC ) up 5.5% in after-hours New York trading, after the company on Wednesday reported a higher adjusted third quarter profit as revenue rose while it raised its fiscal 2024 revenue guidance

Adjusted profit, excluding most one-time items. rose to US$415 million, up 10% from US$377 million last year, primarily due to higher revenue and gross profit. It did not disclose per share results.

Quarterly consolidated revenue rose 12% to US$2.51 billion.

The company also raised its 2024 full year revenue guidance to US$9.5 billion to US$9.675 billion.

"Our team at Bausch Health ( BHC ) continued to execute against our commitments in the third quarter, delivering a sixth consecutive quarter of year-over-year growth in both revenue and Adjusted EBITDA. This was accomplished while we continued to advance our R&D pipeline, including the approval and launch of Cabtreo in Canada. These results reflect the strength of our diverse and robust portfolio of products, both geographically and across therapeutic areas," said Thomas Appio, Chief Executive Officer.

Bausch Health ( BHC ) was last seen up $0.45 to US$8.62 in New York trade. They closed up $0.01 to $11.37 on the Toronto Stock Exchange.